Pharma Manufacturing Digital Twin: Reference Architecture
A vendor-neutral 2026 reference architecture for a pharma manufacturing digital twin: PAT data, GMP validation, batch genealogy, and the closed control loop.
Does Edge AI Actually Cut Cloud Costs? A Fact-Check
Fact-checking the claim that edge AI slashes cloud bills: where the savings are real, where they hide capital and ops costs, and the break-even math for 2026.
Battery Passport and PLM: How EU Rules Reshape Product Data
How the EU battery passport reshapes PLM: the data model, digital product passport schema, supply-chain traceability, and what engineering teams must build by 2027.
Semantic Caching for LLM Applications: Architecture (2026)
A 2026 architecture guide to semantic caching for LLM apps: embedding similarity lookup, cache invalidation, hit-rate tuning, and where it quietly breaks.
RAG Reranker Benchmark: Cohere Rerank vs BGE vs Jina vs ColBERT (2026)
RAG Reranker Benchmark: Cohere Rerank vs BGE vs Jina vs ColBERT (2026) - updated October 2026 with verified facts, diagrams and FAQ.
Apache Pinot vs Apache Druid: Real-Time OLAP ADR (2026)
An ADR-style 2026 comparison of Apache Pinot and Apache Druid for real-time OLAP: ingestion, indexing, query latency, ops cost, and when to pick each.
Cilium Tetragon Runtime Security: eBPF Hands-On (2026)
A hands-on 2026 guide to Cilium Tetragon: eBPF runtime security, TracingPolicy, process and network enforcement, and how it differs from Falco.
Smart Order Routing Engine Architecture (2026)
A 2026 systems design of a smart order routing engine: venue selection, latency budgets, best-execution logic, risk checks, and the failure modes that bite.
Cobalt 200 vs Graviton vs Axion: Cloud Arm Silicon War
Microsoft Cobalt 200 lands in 2026. We compare it with AWS Graviton and Google Axion on architecture, performance-per-watt, and what custom Arm silicon means.
Base Editing Explained: Single-Base CRISPR Therapeutics
Base editing rewrites a single DNA letter without cutting the double helix. How cytosine and adenine base editors work, their off-target limits, and 2026 clinical use.